95 related articles for article (PubMed ID: 19956916)
1. A polymorphism in the hMLH1 gene (-93G-->A) associated with lung cancer susceptibility and prognosis.
Shih CM; Chen CY; Lee IH; Kao WT; Wang YC
Int J Mol Med; 2010 Jan; 25(1):165-70. PubMed ID: 19956916
[TBL] [Abstract][Full Text] [Related]
2. -93G-->A polymorphism of hMLH1 and risk of primary lung cancer.
Park SH; Lee GY; Jeon HS; Lee SJ; Kim KM; Jang SS; Kim CH; Lee WK; Kam S; Park RW; Kim IS; Jung TH; Park JY
Int J Cancer; 2004 Nov; 112(4):678-82. PubMed ID: 15382050
[TBL] [Abstract][Full Text] [Related]
3. Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end-joining pathway genes: a multiple genotype-phenotype study.
Tseng RC; Hsieh FJ; Shih CM; Hsu HS; Chen CY; Wang YC
Cancer; 2009 Jul; 115(13):2939-48. PubMed ID: 19408343
[TBL] [Abstract][Full Text] [Related]
4. Mismatch repair polymorphisms and colorectal polyps: hMLH1-93G>A variant modifies risk associated with smoking.
Yu JH; Bigler J; Whitton J; Potter JD; Ulrich CM
Am J Gastroenterol; 2006 Jun; 101(6):1313-9. PubMed ID: 16771955
[TBL] [Abstract][Full Text] [Related]
5. DNA methylation of hMLH1 correlates with the clinical response to cisplatin after a surgical resection in Non-small cell lung cancer.
Wu F; Lu M; Qu L; Li DQ; Hu CH
Int J Clin Exp Pathol; 2015; 8(5):5457-63. PubMed ID: 26191250
[TBL] [Abstract][Full Text] [Related]
6. Association of genetic polymorphisms of CXCL12/SDF1 gene and its receptor, CXCR4, to the susceptibility and prognosis of non-small cell lung cancer.
Lee YL; Kuo WH; Lin CW; Chen W; Cheng WE; Chen SC; Shih CM
Lung Cancer; 2011 Aug; 73(2):147-52. PubMed ID: 21292343
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic mismatch repair hMSH2 and hMLH1 gene expression profiles in primary non-small cell lung carcinomas.
Vageli D; Daniil Z; Dahabreh J; Karagianni E; Vamvakopoulou DN; Ioannou MG; Scarpinato K; Vamvakopoulos NC; Gourgoulianis KI; Koukoulis GK
Lung Cancer; 2009 Jun; 64(3):282-8. PubMed ID: 19056144
[TBL] [Abstract][Full Text] [Related]
8. Mismatch repair gene polymorphisms and association with lung cancer development.
Slováková P; Majerová L; Matáková T; Skereňová M; Kavcová E; Halašová E
Adv Exp Med Biol; 2015; 833():15-22. PubMed ID: 25252909
[TBL] [Abstract][Full Text] [Related]
9. Expression of mismatch repair proteins, hMLH1/hMSH2, in non-small cell lung cancer tissues and its clinical significance.
Kouso H; Yoshino I; Miura N; Takenaka T; Ohba T; Yohena T; Osoegawa A; Shoji F; Maehara Y
J Surg Oncol; 2008 Oct; 98(5):377-83. PubMed ID: 18646042
[TBL] [Abstract][Full Text] [Related]
10. Single nucleotide polymorphism in hMLH1 promoter and risk of tobacco-related oral carcinoma in high-risk Asian Indians.
Jha R; Gaur P; Sharma SC; Das SN
Gene; 2013 Sep; 526(2):223-7. PubMed ID: 23727610
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms in hMLH1 and risk of early-onset lung cancer in a southeast Chinese population.
An Y; Jin G; Wang H; Wang Y; Liu H; Li R; Wang H; Qian J; Sun W; Wang Y; Ma H; Miao R; Hu Z; Jin L; Wei Q; Shen H; Huang W; Lu D
Lung Cancer; 2008 Feb; 59(2):164-70. PubMed ID: 17870204
[TBL] [Abstract][Full Text] [Related]
12. MLH1 -93G>A promoter polymorphism and the risk of microsatellite-unstable colorectal cancer.
Raptis S; Mrkonjic M; Green RC; Pethe VV; Monga N; Chan YM; Daftary D; Dicks E; Younghusband BH; Parfrey PS; Gallinger SS; McLaughlin JR; Knight JA; Bapat B
J Natl Cancer Inst; 2007 Mar; 99(6):463-74. PubMed ID: 17374836
[TBL] [Abstract][Full Text] [Related]
13. The relationship of metalloproteinase gene polymorphisms and lung cancer.
Sanli M; Akar E; Pehlivan S; Bakır K; Tuncozgur B; Isik AF; Pehlivan M; Elbeyli L
J Surg Res; 2013 Aug; 183(2):517-23. PubMed ID: 23465389
[TBL] [Abstract][Full Text] [Related]
14. Correlation of genetic instability with mismatch repair protein expression and p53 mutations in non-small cell lung cancer.
Chang JW; Chen YC; Chen CY; Chen JT; Chen SK; Wang YC
Clin Cancer Res; 2000 May; 6(5):1639-46. PubMed ID: 10815881
[TBL] [Abstract][Full Text] [Related]
15. The hMLH1 -93G>A promoter polymorphism is associates with outcomes in oral squamous cell carcinoma patients.
Lin LH; Lin MW; Mar K; Lin CS; Ji DD; Lee WP; Lee HS; Cheng MF; Hsia KT
Ann Surg Oncol; 2014 Dec; 21(13):4270-7. PubMed ID: 25047469
[TBL] [Abstract][Full Text] [Related]
16. O6-alkylguanine-DNA alkyltransferase gene polymorphisms and the risk of primary lung cancer.
Chae MH; Jang JS; Kang HG; Park JH; Park JM; Lee WK; Kam S; Lee EB; Son JW; Park JY
Mol Carcinog; 2006 Apr; 45(4):239-49. PubMed ID: 16385589
[TBL] [Abstract][Full Text] [Related]
17. hMLH1 and hMSH2 expression correlates with allelic imbalance on chromosome 3p in non-small cell lung carcinomas.
Xinarianos G; Liloglou T; Prime W; Maloney P; Callaghan J; Fielding P; Gosney JR; Field JK
Cancer Res; 2000 Aug; 60(15):4216-21. PubMed ID: 10945633
[TBL] [Abstract][Full Text] [Related]
18. The hMLH1 promoter polymorphisms and cancer susceptibility in Asian populations: a meta-analysis.
He Y; Xu X; Chen H; Wang J; Xiong W; Xu Y; Liu J
Gene; 2013 Jul; 523(2):199-204. PubMed ID: 23587910
[TBL] [Abstract][Full Text] [Related]
19. p53 codon 72 polymorphism in Taiwanese lung cancer patients: association with lung cancer susceptibility and prognosis.
Wang YC; Chen CY; Chen SK; Chang YY; Lin P
Clin Cancer Res; 1999 Jan; 5(1):129-34. PubMed ID: 9918210
[TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients.
Gautschi O; Hugli B; Ziegler A; Bigosch C; Bowers NL; Ratschiller D; Jermann M; Stahel RA; Heighway J; Betticher DC
Lung Cancer; 2006 Mar; 51(3):303-11. PubMed ID: 16406195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
